PEAK6 Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,500
Closed -$279K 5385
2016
Q3
$279K Buy
3,500
+300
+9% +$24.2K ﹤0.01% 2870
2016
Q2
$250K Sell
3,200
-1,100
-26% -$78.4K ﹤0.01% 2977
2016
Q1
$237K Sell
4,300
-1,500
-26% -$81.7K ﹤0.01% 2982
2015
Q4
$358K Sell
5,800
-6,800
-54% -$429K ﹤0.01% 2924
2015
Q3
$795K Buy
12,600
+2,500
+25% +$178K ﹤0.01% 2446
2015
Q2
$738K Buy
10,100
+4,200
+71% +$303K ﹤0.01% 2382
2015
Q1
$386K Buy
5,900
+2,900
+97% +$193K ﹤0.01% 2825
2014
Q4
$195K Buy
+3,000
New +$193K ﹤0.01% 3390
2014
Q2
Sell
-22,600
Closed -$1.48M 5503
2014
Q1
$1.48M Sell
22,600
-4,200
-16% -$273K 0.01% 1520
2013
Q4
$1.66M Sell
26,800
-111,800
-81% -$6.47M 0.01% 1589
2013
Q3
$3.72M Buy
138,600
+130,600
+1,633% +$6.73M 0.03% 1023
2013
Q2
$365 Buy
+8,000
New +$347K ﹤0.01% 3089

Other funds holding STJ

PEAK6 Group's STJ Position: Q1 2017 in Review

PEAK6 Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 59,968 shares — an estimated $4.81M sold.

PEAK6 Group first reported a position in STJ in Q4 2014 and held it in 3 quarters. The position peaked at $4.81M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • PEAK6 Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • PEAK6 Group sold 59,968 St Jude Medical shares in Q1 2017, an estimated $4.81M.
  • PEAK6 Group first reported a position in St Jude Medical in Q4 2014 and held it in 3 quarters.
  • PEAK6 Group's St Jude Medical position peaked at $4.81M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.